View Older Stories View More Recent Stories

Jun 27, 2025 10:53AM Gilead Sciences (GILD) call put ratio 1.2 calls to 1 put as share price up 1.4%
Jun 27, 2025 10:36AM Exact Sciences (EXAS), Gilead Sciences (GILD) Spike Higher
Jun 25, 2025 12:43PM Kymera Therapeutics (KYMR) PT Lowered to $64 at Jefferies
Jun 25, 2025 07:02AM Gilead Sciences (GILD) and Kymera Therapeutics (KYMR) Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders
Jun 18, 2025 03:41PM Gilead Sciences (GILD) Yeztugo Label 'Looks Clean' - Mizuho
Jun 18, 2025 03:21PM Gilead Sciences (GILD) Yeztugo approval a 'major win' - BMO Capital
Jun 18, 2025 02:50PM Gilead Sciences (GILD): Yeztugo Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
Jun 13, 2025 11:43AM Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
Jun 11, 2025 09:09AM Gilead Sciences (GILD) PT Raised at RBC Capital Following Patient Survey
Jun 10, 2025 11:14AM FDA clinical hold a 'blow to Gilead Sciences (GILD) HIV pipeline - Oppenheimer
Jun 10, 2025 10:21AM Gilead Sciences shares hit after HIV studies placed on hold by FDA
Jun 10, 2025 09:47AM RBC Capital on Gilead Sciences (GILD): 'We Would Look for a Better Entry Point'
Jun 10, 2025 09:17AM Gilead Sciences (GILD) Says FDA Placed Cilnical Hold On Hiv Treatment Trials
Jun 10, 2025 05:47AM Gilead Sciences (GILD) call put ratio 1 call to 1.3 puts as share price near upper end of range
Jun 3, 2025 05:02AM Morgan Stanley Reiterates Overweight Rating on Gilead Sciences (GILD)
Jun 2, 2025 11:03AM Gilead Sciences (GILD) Shares Drop To Session Low, Down Over 3%
Jun 2, 2025 05:04AM Citi Reiterates Buy Rating on Gilead Sciences (GILD)
May 24, 2025 10:00PM What can get the U.S. large-cap pharma sector to work?
May 23, 2025 08:32AM Gilead Sciences (GILD) announces positive data from Phase 3 Trodelvy study
May 7, 2025 03:10PM Gilead Sciences to invest $11 billion in U.S. R&D and manufacturing
May 7, 2025 02:57PM Gilead Sciences (GILD) U.S. Investment to Create $43B in Value to U.S. Economy
May 7, 2025 05:30AM Gilead Sciences (GILD) call put ratio 1 call to 4.4 puts
May 4, 2025 04:00AM Will the HIV/AIDS payer landscape change?
Apr 29, 2025 08:31AM Gilead Sciences (GILD) to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis
Apr 24, 2025 04:03PM Gilead Sciences (GILD) Tops Q1 EPS by 4c; maintains guidance
Apr 24, 2025 05:16AM Gilead Sciences (GILD) call put ratio 1 call to 1 put into quarter results
Apr 22, 2025 08:05AM Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD)
Apr 22, 2025 08:02AM Bernstein on Gilead Sciences (GILD): 'TNBC is a Meaningful Opportunity'
Apr 22, 2025 07:20AM Cantor Fitzgerald Assumes Gilead Sciences (GILD) at Overweight
Apr 21, 2025 08:31AM Gilead Sciences (GILD); Trodelvy Plus Keytruda Demonstrates Statistically Significant and Clinically Meaningful Improvement in PFS in Patients With nTNBC
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks
Mar 19, 2025 10:08AM Citi Defending Gilead Sciences (GILD): 'we are buyers of GILD stock on any weakness ahead of the upcoming Len PrEP launch in mid-2025'
Mar 19, 2025 10:05AM BMO Capital Reiterates Outperform on Gilead Sciences (GILD) Amid 'Potential HHS HIV Funding Cuts'
Mar 19, 2025 04:03AM Gilead Sciences (GILD) call put ratio 1 call to 2.5 puts amid price movement
Mar 18, 2025 04:35PM After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more
Mar 18, 2025 04:12PM Gilead Sciences (GILD) Weakness Tied to Reports Trump Admin Planning Major Funding Cuts for HIV Prevention
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Mar 12, 2025 09:35AM Bernstein SocGen Group Reiterates Outperform Rating on Gilead Sciences (GILD)
Mar 12, 2025 08:31AM Gilead Sciences (GILD) Presents New HIV Treatment and Cure Research Data
Mar 11, 2025 01:38PM Gilead Sciences (GILD) Presents First Clinical Data for Investigational Once-Yearly Lenacapavir for HIV Prevention
Mar 4, 2025 08:23AM Gilead Sciences (GILD) PT Raised to $132 at Oppenheimer
Feb 18, 2025 09:46AM Morgan Stanley Reiterates Overweight Rating on Gilead Sciences (GILD)
Feb 18, 2025 08:30AM Gilead Sciences (GILD): U.S. FDA Accepts New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Feb 18, 2025 06:57AM Arcus Biosciences (RCUS) Retains Rights to Casdatifan, and Announces Pricing of $150 Million Common Stock Offering
Feb 12, 2025 12:38PM Gilead Sciences (GILD) PT Raised to $100 at TD Cowen Following 'Strong Top & Bottom Beat'
Feb 12, 2025 11:39AM RBC: 'Gilead Sciences (GILD) Exits 2024 On Strong Note'; PT Raised
Feb 12, 2025 10:30AM Gilead Sciences (GILD) PT Raised to $115 at BMO Capital; 'More Growth Coming in 25'
View More Recent Stories View Older Stories